|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2008;135:1400-1401
© 2008 The American Association for Thoracic Surgery
Letter to the Editor |
a Department of Surgery, University of Cambridge, Cambridge, United Kingdom
b Department of Cardiac Surgery, St George's Hospital Medical School, London, United Kingdom
To the Editor:
We read with interest the meta-analysis of randomized studies of neurocognitive decline after on-pump versus off-pump coronary artery bypass graft surgery (CABG) by Takagi and colleagues.1
The inclusion criteria comprised prospective randomized studies with the incidence of postoperative neurocognitive decline as the primary end point. However, there was significant clinical heterogeneity in the studies that were included in the meta-analysis. In particular, the definitions used to define neurocognitive decline between the trials varied markedly.2,3
As a result, we question whether the incidences of neurocognitive decline can be reliably compared. Furthermore, studies that derive an incidence value for neurocognitive impairment after CABG are prone to the statistical phenomenon of regression to the mean (RTM).4
RTM explains much of the neurocognitive deficits that have been reported with the use of incidence analysis.
At present, there is no agreement as to what degree of change constitutes neuropsychological dysfunction. In one study of patients undergoing CABG, the incidence of postoperative neurocognitive dysfunction varied considerably according to the definition of neurocognitive decline.5
Incidence figures superficially provide a convenient summation of the extent of impairment, but they are calculated by imposing an arbitrary statistical constraint on individual test measures. As such, overall incidence data will vary according to which statistical criteria are used, the sensitivity and number of tests used, and the type of cognitive domains they assess.5
Any approach that essentially dichotomizes patients as "impaired" or "unimpaired" is a costly way of data handling that reduces statistical power.
Whereas a specific definition of neurocognitive impairment is required when the study objective is to determine the incidence of postoperative neurocognitive dysfunction, it is not necessary when one wants to test a specific hypothesis such as the effects of an intervention, for example, off-pump surgery. It is far better to use continuous measures inasmuch as they provide greater statistical power and allow more sophisticated analyses. Recently, we6
reported neurocognitive outcomes in 212 patients prospectively randomized to on-pump or off-pump CABG. We derived composite scores from all the individual test scores and avoided categorizing patients as "cognitively impaired or not," thus treating the test scores as a continuous variable. Therefore, any subtle changes in test scores will have contributed to the overall effect size. In addition, we compared the postoperative scores having adjusted for preoperative scores by using analysis of covariance. This takes RTM into account and is a powerful method of analysing test–retest data.
In summary, asking how often neurocognitive dysfunction occurs after CABG, and expecting a simple one-sided answer to suffice, is simplistic, however desirable. When neuropsychologic tests are used to test a certain hypothesis, as in this investigation, one does not need to set an arbitrary definition of neurocognitive decline to categorize individuals into those with or without a neurocognitive deficit. Instead, one can look at change and its relative difference between groups, which greatly enhances the power of the analysis.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |